Financials
- Market Capitalization 3.69 M
- Employee 2
- Founded 2007
- CEO N/A
- Website www.propanc.com
- Headquarter Delaware, United States
- FIGI BBG002086386
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.29
売上高対価格比率
-439.06
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4798 | APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 0.77 USD | +4.05% | -1.28% | -38.40% | -41.22% | 11.62 M USD | ||
| 4896 | KAPA Kairos Pharma, Ltd. Common Stock | 0.34 USD | 0.00% | -8.11% | -24.44% | -41.38% | 7.28 M USD | ||
| 5062 | DCOY Decoy Therapeutics Inc. - Common Stock | 5.80 USD | -0.68% | -17.38% | -9.38% | +617.11% | 3.09 M USD | ||
| 5102 | VIVS VivoSim Labs, Inc. - Common Stock | 0.81 USD | 0.00% | -10.99% | -30.77% | -57.59% | 2.11 M USD |